| 1GOS |
3.0 |
Human Monoamine Oxidase B |
| 1OJ9 |
2.3 |
HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE |
| 1OJA |
1.7 |
HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN |
| 1OJC |
2.4 |
HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-aminoethyl)-p-chlorobenzamide |
| 1OJD |
3.1 |
HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH Lauryldimethylamine-N-oxide (LDAO) |
| 1S2Q |
2.07 |
Crystal structure of MAOB in complex with N-propargyl-1(R)-aminoindan (Rasagiline) |
| 1S2Y |
2.12 |
Crystal structure of MAOB in complex with N-propargyl-1(S)-aminoindan |
| 1S3B |
1.65 |
Crystal structure of MAOB in complex with N-methyl-N-propargyl-1(R)-aminoindan |
| 1S3E |
1.6 |
Crystal structure of MAOB in complex with 6-hydroxy-N-propargyl-1(R)-aminoindan |
| 2BK3 |
1.8 |
Human Monoamine Oxidase B in complex with Farnesol |
| 2BK4 |
1.9 |
Human Monoamine Oxidase B: I199F mutant in complex with rasagiline |
| 2BK5 |
1.83 |
Human Monoamine Oxidase B: I199F mutant in complex with isatin |
| 2BYB |
2.2 |
Human Monoamine Oxidase B in complex with Deprenyl |
| 2C64 |
2.2 |
MAO inhibition by rasagiline analogues |
| 2C65 |
1.7 |
MAO inhibition by rasagiline analogues |
| 2C66 |
2.5 |
MAO inhibition by rasagiline analogues |
| 2C67 |
1.7 |
MAO inhibition by rasagiline analogues |
| 2C70 |
2.06 |
Functional Role of the Aromatic Cage in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins |
| 2C72 |
2.0 |
Functional Role of the Aromatic Cage in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins |
| 2C73 |
2.2 |
Functional Role of the Aromatic Cage in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins |
| 2C75 |
1.7 |
Functional Role of the Aromatic Cage in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins |
| 2C76 |
1.7 |
Functional Role of the Aromatic Cage in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins |
| 2V5Z |
1.6 |
Structure of human MAO B in complex with the selective inhibitor safinamide |
| 2V60 |
2.0 |
Structure of human MAO B in complex with the selective inhibitor 7-(3- chlorobenzyloxy)-4-carboxaldehyde-coumarin |
| 2V61 |
1.7 |
Structure of human MAO B in complex with the selective inhibitor 7-(3- chlorobenzyloxy)-4-(methylamino)methyl-coumarin |
| 2VRL |
2.4 |
Structure of human MAO B in complex with benzylhydrazine |
| 2VRM |
2.3 |
Structure of human MAO B in complex with phenyethylhydrazine |
| 2VZ2 |
2.3 |
Human MAO B in complex with mofegiline |
| 2XCG |
1.9 |
Tranylcypromine-inhibited human monoamine oxidase B in complex with 2- (2-benzofuranyl)-2-imidazoline |
| 2XFN |
1.6 |
Human monoamine oxidase B in complex with 2-(2-benzofuranyl)-2- imidazoline |
| 2XFO |
2.1 |
tranylcypromine-inhibited human monoamine oxidase B Ile199Ala mutant in complex with 2-(2-benzofuranyl)-2-imidazoline |
| 2XFP |
1.66 |
Isatin-inhibited human monoamine oxidase B in complex with 2-(2- benzofuranyl)-2-imidazoline |
| 2XFQ |
2.2 |
Rasagiline-inhibited human monoamine oxidase B in complex with 2-(2- benzofuranyl)-2-imidazoline |
| 2XFU |
2.2 |
Human monoamine oxidase B with tranylcypromine |
| 3PO7 |
1.8 |
Human monoamine oxidase B in complex with zonisamide |
| 3ZYX |
2.2 |
Crystal structure of human monoamine oxidase B in complex with methylene blue and bearing the double mutation I199A-Y326A |
| 4A79 |
1.89 |
Crystal structure of human monoamine oxidase B (MAO B) in complex with pioglitazone |
| 4A7A |
1.7 |
Crystal structure of human monoamine oxidase B (MAO B) in complex with rosiglitazone |
| 4CRT |
1.8 |
Crystal structure of human monoamine oxidase B in complex with the multi-target inhibitor ASS234 |
| 5MRL |
2.42 |
Crystal structure of human monoamine oxidase B (MAO B) in complex with N(Furan2ylmethyl)Nmethylprop2yn1amine (F2MPA) |
| 6FVZ |
1.8 |
Crystal structure of human monoamine oxidase B (MAO B) in complex with dimethylphenyl-chromone-carboxamide |
| 6FW0 |
1.6 |
Crystal structure of human monoamine oxidase B (MAO B) in complex with chlorophenyl-chromone-carboxamide |
| 6FWC |
1.7 |
Crystal structure of human monoamine oxidase B (MAO B) in complex with fluorophenyl-chromone-carboxamide |
| 6RKB |
2.3 |
Crystal structure of human monoamine oxidase B in complex with styrylpiperidine analogue 1 |
| 6RKP |
1.7 |
Crystal structure of human monoamine oxidase B in complex with styrylpiperidine analogue 84 |
| 6RLE |
2.3 |
Crystal structure of human monoamine oxidase B in complex with styrylpiperidine analogue 97 |
| 6YT2 |
1.8 |
Crystal Structure of human monoamine oxidase B in complex with Diphenylene iodonium (DPI) |
| 7B0V |
2.3 |
Crystal Structure of human monoamine oxidase B in complex with (E)-3-phenyl-1-(3-(trifluoromethyl)phenyl)prop-2-en-1-one |
| 7B0Z |
2.1 |
Crystal Structure of human monoamine oxidase B in complex with (E)-3-phenyl-1-(4-(trifluoromethyl)phenyl)prop-2-en-1-one |
| 7P4F |
2.3 |
Crystal Structure of Monoamine Oxidase B in complex with inhibitor 1 |
| 7P4H |
2.1 |
Crystal Structure of Monoamine Oxidase B in complex with inhibitor (+)-2 |
| 7ZW3 |
2.0 |
Crystal Structure of human MAO B in complex with (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide (inhibitor 19) |
